These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys. Cho IK; Yang B; Forest C; Qian L; Chan AWS PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183 [TBL] [Abstract][Full Text] [Related]
25. Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs. Tong H; Yang T; Liu L; Li C; Sun Y; Jia Q; Qin Y; Chen L; Zhao X; Zhou G; Yan S; Li XJ; Li S Neurobiol Dis; 2023 Oct; 187():106291. PubMed ID: 37716514 [TBL] [Abstract][Full Text] [Related]
26. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy. Carbo M; Brandi V; Pascarella G; Staid DS; Colotti G; Polticelli F; Ilari A; Morea V Int J Mol Med; 2019 Dec; 44(6):2223-2233. PubMed ID: 31638189 [TBL] [Abstract][Full Text] [Related]
27. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice. Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705 [TBL] [Abstract][Full Text] [Related]
29. Soluble N-terminal fragment of mutant Huntingtin protein impairs mitochondrial axonal transport in cultured hippocampal neurons. Tian J; Yan YP; Zhou R; Lou HF; Rong Y; Zhang BR Neurosci Bull; 2014 Feb; 30(1):74-80. PubMed ID: 24362588 [TBL] [Abstract][Full Text] [Related]
30. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Damiano M; Diguet E; Malgorn C; D'Aurelio M; Galvan L; Petit F; Benhaim L; Guillermier M; Houitte D; Dufour N; Hantraye P; Canals JM; Alberch J; Delzescaux T; Déglon N; Beal MF; Brouillet E Hum Mol Genet; 2013 Oct; 22(19):3869-82. PubMed ID: 23720495 [TBL] [Abstract][Full Text] [Related]
31. In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using Bertoglio D; Weiss AR; Liguore W; Martin LD; Hobbs T; Templon J; Srinivasan S; Dominguez C; Munoz-Sanjuan I; Khetarpal V; Verhaeghe J; Staelens S; Link J; Liu L; Bard JA; McBride JL J Nucl Med; 2023 Oct; 64(10):1581-1587. PubMed ID: 37591545 [TBL] [Abstract][Full Text] [Related]
32. CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease. Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368337 [TBL] [Abstract][Full Text] [Related]
33. Mutant huntingtin protein induces MLH1 degradation, DNA hyperexcision, and cGAS-STING-dependent apoptosis. Sun X; Liu L; Wu C; Li X; Guo J; Zhang J; Guan J; Wang N; Gu L; Yang XW; Li GM Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2313652121. PubMed ID: 38498709 [TBL] [Abstract][Full Text] [Related]
35. Detection of antibodies against the huntingtin protein in human plasma. Denis HL; Alpaugh M; Alvarez CP; Fenyi A; Barker RA; Chouinard S; Arrowsmith CH; Melki R; Labib R; Harding RJ; Cicchetti F Cell Mol Life Sci; 2023 Jan; 80(2):45. PubMed ID: 36651994 [TBL] [Abstract][Full Text] [Related]
36. Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients. Pierzynowska K; Gaffke L; Cyske Z; Węgrzyn G Metab Brain Dis; 2019 Jun; 34(3):715-720. PubMed ID: 30850940 [TBL] [Abstract][Full Text] [Related]
37. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD). Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346 [TBL] [Abstract][Full Text] [Related]
38. Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington's disease: an in vivo high-content imaging study. Carty N; Berson N; Tillack K; Thiede C; Scholz D; Kottig K; Sedaghat Y; Gabrysiak C; Yohrling G; von der Kammer H; Ebneth A; Mack V; Munoz-Sanjuan I; Kwak S PLoS One; 2015; 10(4):e0123527. PubMed ID: 25859666 [TBL] [Abstract][Full Text] [Related]
39. Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease. Morena E; Romano C; Marconi M; Diamant S; Buscarinu MC; Bellucci G; Romano S; Scarabino D; Salvetti M; Ristori G Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047023 [TBL] [Abstract][Full Text] [Related]
40. Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease. Pfister EL; DiNardo N; Mondo E; Borel F; Conroy F; Fraser C; Gernoux G; Han X; Hu D; Johnson E; Kennington L; Liu P; Reid SJ; Sapp E; Vodicka P; Kuchel T; Morton AJ; Howland D; Moser R; Sena-Esteves M; Gao G; Mueller C; DiFiglia M; Aronin N Hum Gene Ther; 2018 Jun; 29(6):663-673. PubMed ID: 29207890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]